Results 291 to 300 of about 250,000 (338)
Some of the next articles are maybe not open access.

Peroxisome proliferator activated receptors and obesity

European Journal of Pharmacology, 2002
The peroxisome proliferator activated receptors (PPARs) are a group of ligand-activated transcription factors that govern numerous biological processes, including energy metabolism, cell proliferation, and inflammation. Three different PPAR isotypes can be distinguished: alpha, beta and gamma.
openaire   +2 more sources

Peroxisome Proliferator Activated Receptors

2005
The metabolic activity of the liver plays a central role in coordinating the supply of energy to peripheral organs, in particular the brain. It is at the heart of an adaptive system, which allows survival at times of food deprivation and governs the storage of excess energy when plenty of food is available.
Raphaël Genolet   +2 more
openaire   +1 more source

Peroxisome Proliferator-Activated Receptors

Journal of Biological Research and Reviews
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that regulate key physiological processes, including lipid metabolism, glucose homeostasis, and inflammation. The three subtypes, PPAR-alpha, PPAR-beta/delta, and PPAR-gamma, have distinct roles and tissue distributions, making them promising targets for metabolic and ...
Robert Ringseis, Klaus Eder
openaire   +2 more sources

Peroxisome proliferator-activated receptor ligands in atherosclerosis

Expert Opinion on Investigational Drugs, 2004
In this review, the effect of peroxisome proliferator-activated receptor (PPAR) ligands on atherosclerosis is examined. The PPAR-gamma agonist thiazolidinediones are currently indicated for the management of Type 2 diabetes mellitus, and the PPAR-alpha agonist fibrates are used in dyslipidaemia.
Juan F, Viles-Gonzalez   +3 more
openaire   +2 more sources

Peroxisome Proliferator‐activated Receptors: Stuctures and Function

Annals of the New York Academy of Sciences, 1996
We have been attempting to elucidate the molecular mechanisms through which peroxisome proliferators exert their pleiotropic effects, with particular emphasis on understanding why humans appear unresponsive to these compounds. There is a wealth of data to implicate the peroxisome proliferator-activated receptor alpha (PPAR alpha) in mediating these ...
J D, Tugwood   +4 more
openaire   +2 more sources

Transcription coactivators for peroxisome proliferator-activated receptors

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
Peroxisome proliferator-activated receptors (PPARs) regulate diverse biological processes such as development, differentiation, neoplastic conversion, inflammation and wound healing in addition to their critical roles in energy (lipid and carbohydrate) metabolism.
Songtao, Yu, Janardan K, Reddy
openaire   +2 more sources

Drugs targeting peroxisome proliferator-activated receptors

Drug Discovery Today
The year 2024 witnessed the accelerated approvals of two peroxisome proliferator-activated receptor (PPAR) agonists for the treatment of primary biliary cholangitis (PBC). PPARs, including three isoforms (PPARα, PPARγ, and PPARδ), are therapeutic targets generating considerable debate yet also seeing significant advances in their successful targeting ...
Zhouling Xie   +3 more
openaire   +2 more sources

An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*)

Journal of Biological Chemistry, 1995
J. Lehmann   +5 more
semanticscholar   +1 more source

Peroxisome proliferator activated receptors and stroke

Current Atherosclerosis Reports, 2003
Jean-Charles, Fruchart   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy